Ophthalmology Times Europeophthalmology news, features, events and interviews in cataract, refractive, glaucoma, retina and much more.Suicide risk in visually impaired- July 28, 2008 Visual impairment is associated with an increased risk of suicide, according to results of a study published in the July 2008 issue of the Archives of Ophthalmology.http://www.oteurope.com/ophthalmologytimeseurope/Refractive+news/Suicide-risk-in-visually-... IOP-detecting contact lens built- July 28, 2008 A refinement in the manufacturing of contact lens material has enabled scientists to build a contact lens with an integrated sensor than can detect changes in intraocular pressure (IOP), according to results published in the July 2008 issue of Advanced Functional Materials.http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/IOP-detecting-contact-lens-... Avastin effective against ROP- July 28, 2008 Intravitreal bevacizumab (Avastin) can be beneficial in the treatment of severe retinopathy of prematurity (ROP), according to a study published in the July 2008 issue of the British Journal of Ophthalmology.http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Avastin-effective-against-ROP... Timolol recall- July 28, 2008 Bottles of timolol ophthalmic solution 0.25% and 0.5% (Sandoz Canada Inc.) have been recalled in Canada because of an increased risk of adverse events.http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+news/Timolol-recall/ArticleStand... Free retinal screening for diabetics- July 28, 2008 All diagnosed diabetics aged 12 years and over should have access to free, annual retinal screening, according to Diabetes UK's Your Vision awareness campaign.http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Free-retinal-screening-for-di... Once-daily insert designed to provide lasting dry eye relief- July 28, 2008 A hydroxypropyl cellulose ophthalmic insert (Lacrisert, Aton Pharma) is a preservative-free product recommended for once-daily insertion in the inferior cul-de-sac. Its convenience, efficacy, and safety make it a valuable option for the management of dry eye disease.http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Once-daily-insert-designed-to... Avastin tackles retinoblastoma- July 28, 2008 Bevacizumab (Avastin) has been shown to inhibit angiogenesis and growth of retinoblastoma, according to results of a study published in the July 2008 issue of the Archives of Ophthalmology.http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Avastin-tackles-retinoblastom... MICS: gauge width impacts wound- July 28, 2008 Gauges and knives used during microincision cataract surgery (MICS) should be of equal thickness, according to a study published in the July 2008 issue of the Journal of Cataract & Refractive Surgery.http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/MICS-gauge-width-impacts-wo... Alcon drops AMD candidate- July 21, 2008 Following disappointing clinical trial results, Alcon has discontinued its plans to develop anecortave acetate for the prevention of choroidal neovascularization secondary to age-related macular degeneration (AMD).http://www.oteurope.com/ophthalmologytimeseurope/Retina+news/Alcon-drops-AMD-candidate/Art... Novartis a step closer to Alcon purchase- July 21, 2008 Novartis has completed the first stage of its purchase of 74 million shares of common stock of Alcon. This step maintains Nestle as the majority shareholder of Alcon, with 52% of the company's issued capital, and establishes Novartis as a minority shareholder, holding 24.85% of Alcon's shares.http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Novartis-a-step-closer-to-Alc... |